Extracellular vesicles from dHL-60 cells as delivery vehicles for diverse therapeutics

Sci Rep. 2021 Apr 15;11(1):8289. doi: 10.1038/s41598-021-87891-8.

Abstract

Extracellular vesicles (EVs) are membrane-derived heterogeneous vesicles that mediate intercellular communications. They have recently been considered as ideal vehicles for drug-delivery systems, and immune cells are suggested as a potential source for drug-loaded EVs. In this study, we investigated the possibility of neutrophils as a source for drug-loaded EVs. Neutrophil-like differentiated human promyelocytic leukemia cells (dHL-60) produced massive amounts of EVs within 1 h. The dHL-60 cells are also easily loaded with various cargoes such as antibiotics (penicillin), anticancer drug (paclitaxel), chemoattractant (MCP-1), miRNA, and Cas9. The EVs derived from the dHL-60 cells showed efficient incorporation of these cargoes and significant effector functions, such as bactericidal activity, monocyte chemotaxis, and macrophage polarization. Our results suggest that neutrophils or neutrophil-like promyelocytic cells could be an attractive source for drug-delivery EVs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Antineoplastic Agents / administration & dosage
  • Cell Communication
  • Cell Differentiation
  • Cells, Cultured
  • Chemokine CCL2 / administration & dosage
  • Drug Delivery Systems*
  • Extracellular Vesicles*
  • Granulocyte Precursor Cells* / cytology
  • Humans
  • Neutrophils / cytology
  • Paclitaxel / administration & dosage
  • Penicillins / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • CCL2 protein, human
  • Chemokine CCL2
  • Penicillins
  • Paclitaxel